US 11123295
Encholeated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections
granted A61KA61K31/4196A61K31/496
Quick answer
US patent 11123295 (Encholeated antifungal compounds for central nervous system delivery and treatment of Cryptococcus infections) held by MATINAS BIOPHARMA NANOTECHNOLOGIES, INC. expires Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- MATINAS BIOPHARMA NANOTECHNOLOGIES, INC.
- Grant date
- Tue Sep 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 16 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K31/4196, A61K31/496, A61K31/506, A61K31/513